Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: REACTION BIOLOGY CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-01 to 2024-08-31
Current total value of award: $16480.8
Description: TEST THIRTY-FIVE (35) NOVEL SMALL MOLECULE COMPOUNDS FOR INHIBITION OF A SET OF 3 WILD-TYPE KINASE ENZYMES.